Hiroyuki Okuzawa

President and CEO
· tracked since May 2026
Calls
1
Win Rate
100.0%
return
+5.6%
Calls 1 1 Posts tracked · 0.0/day
Calls
7d 0
30d 0
90d 0
Best Calls
DSNKY Long +5.6%
Worst Calls
No live losers yet
Most Mentioned
DSNKY ×1
Recent Calls
DSNKY Long 3 months ago
Win Rate 100% Long 1 Short 0
Win Rate
7d 0%
30d 0%
90d 100%
Average Return +5.6% Long Return +5.6% Short Return -
Average Return
7d -3.2%
30d -7.0%
90d +3.9%
Loading charts...
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
DSNKY Daiichi ... Daiichi Sankyo Comp...
Long
May 12
$17.05
+5.6%
Strong product growth drives continued upside.
Daiichi Sankyo's flagship oncology products are growing strongly, with one expected to reach nearly 1 trillion yen in annual sales and another above 100 billion yen. Despite conservative guidance, the fundamental business is robust and will drive continued growth over the next five years.
Pharma & Biotech
YOUTUBE
Showing 1 of 1 calls · sorted by mentions

Hiroyuki Okuzawa has 1 trade ideas tracked on Buzzberg across 1 tickers since May 2026. Most covered: DSNKY.